<?xml version="1.0" encoding="UTF-8"?>
<ref id="b5-1040986">
 <label>5.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Raetz</surname>
    <given-names>EA</given-names>
   </name>
   <name>
    <surname>Cairo</surname>
    <given-names>MS</given-names>
   </name>
   <name>
    <surname>Borowitz</surname>
    <given-names>MJ</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): phase II results from Children's Oncology Group (COG) study ADVL04P2</article-title>. 
  <source>Pediatr Blood Cancer</source>. 
  <year>2015</year>;
  <volume>62</volume>(
  <issue>7</issue>):
  <fpage>1171</fpage>â€“
  <lpage>1175</lpage>.
  <pub-id pub-id-type="pmid">25732247</pub-id>
 </mixed-citation>
</ref>
